• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基准剂量方法简介及美国环保署基准剂量软件(BMDS)版本 2.1.1。

Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1.

机构信息

U.S. Environmental Protection Agency, National Center for Environmental Assessment, Research Triangle Park, NC 27711, USA.

出版信息

Toxicol Appl Pharmacol. 2011 Jul 15;254(2):181-91. doi: 10.1016/j.taap.2010.10.016. Epub 2010 Oct 27.

DOI:10.1016/j.taap.2010.10.016
PMID:21034758
Abstract

Traditionally, the No-Observed-Adverse-Effect-Level (NOAEL) approach has been used to determine the point of departure (POD) from animal toxicology data for use in human health risk assessments. However, this approach is subject to substantial limitations that have been well defined, such as strict dependence on the dose selection, dose spacing, and sample size of the study from which the critical effect has been identified. Also, the NOAEL approach fails to take into consideration the shape of the dose-response curve and other related information. The benchmark dose (BMD) method, originally proposed as an alternative to the NOAEL methodology in the 1980s, addresses many of the limitations of the NOAEL method. It is less dependent on dose selection and spacing, and it takes into account the shape of the dose-response curve. In addition, the estimation of a BMD 95% lower bound confidence limit (BMDL) results in a POD that appropriately accounts for study quality (i.e., sample size). With the recent advent of user-friendly BMD software programs, including the U.S. Environmental Protection Agency's (U.S. EPA) Benchmark Dose Software (BMDS), BMD has become the method of choice for many health organizations world-wide. This paper discusses the BMD methods and corresponding software (i.e., BMDS version 2.1.1) that have been developed by the U.S. EPA, and includes a comparison with recently released European Food Safety Authority (EFSA) BMD guidance.

摘要

传统上,无观察到不良效应水平 (NOAEL) 方法已被用于确定从动物毒理学数据出发的临界点 (POD),以便用于人类健康风险评估。然而,这种方法存在许多已被明确定义的局限性,例如严格依赖于研究中确定关键效应的剂量选择、剂量间隔和样本量。此外,NOAEL 方法未能考虑剂量反应曲线的形状和其他相关信息。基准剂量 (BMD) 方法最初是在 20 世纪 80 年代作为 NOAEL 方法的替代方法提出的,它解决了 NOAEL 方法的许多局限性。它对剂量选择和间隔的依赖性较小,并考虑了剂量反应曲线的形状。此外,估计 BMD 的 95%下限置信限 (BMDL) 会导致 POD 适当考虑研究质量(即样本量)。随着最近用户友好的 BMD 软件程序的出现,包括美国环境保护署 (U.S. EPA) 的基准剂量软件 (BMDS),BMD 已成为全球许多健康组织的首选方法。本文讨论了美国环境保护署 (U.S. EPA) 开发的 BMD 方法和相应的软件(即 BMDS 版本 2.1.1),并与最近发布的欧洲食品安全局 (EFSA) BMD 指南进行了比较。

相似文献

1
Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1.基准剂量方法简介及美国环保署基准剂量软件(BMDS)版本 2.1.1。
Toxicol Appl Pharmacol. 2011 Jul 15;254(2):181-91. doi: 10.1016/j.taap.2010.10.016. Epub 2010 Oct 27.
2
The benchmark dose method--review of available models, and recommendations for application in health risk assessment.基准剂量法——现有模型综述及在健康风险评估中的应用建议。
Crit Rev Toxicol. 2003;33(5):505-42.
3
Evaluation of the benchmark dose for point of departure determination for a variety of chemical classes in applied regulatory settings.应用监管环境中各种化学类别用于确定起始点的基准剂量评估。
Risk Anal. 2012 May;32(5):830-5. doi: 10.1111/j.1539-6924.2011.01732.x. Epub 2011 Nov 29.
4
Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.使用聚类定性数据对基准剂量和置信限进行自助法估计。
Risk Anal. 2007 Apr;27(2):447-65. doi: 10.1111/j.1539-6924.2007.00897.x.
5
Health assessment of phosgene: approaches for derivation of reference concentration.光气的健康评估:参考浓度推导方法
Regul Toxicol Pharmacol. 2008 Jun;51(1):98-107. doi: 10.1016/j.yrtph.2008.03.004. Epub 2008 Mar 21.
6
Identification of a critical dose level for risk assessment: developments in benchmark dose analysis of continuous endpoints.确定用于风险评估的关键剂量水平:连续终点的基准剂量分析进展
Toxicol Sci. 2006 Mar;90(1):241-51. doi: 10.1093/toxsci/kfj057. Epub 2005 Dec 1.
7
Does EU legislation allow the use of the Benchmark Dose (BMD) approach for risk assessment?欧盟法规是否允许使用基准剂量(BMD)方法进行风险评估?
Regul Toxicol Pharmacol. 2013 Nov;67(2):182-8. doi: 10.1016/j.yrtph.2013.07.005. Epub 2013 Jul 16.
8
Development of an occupational exposure limit for n-propylbromide using benchmark dose methods.使用基准剂量法制定正丙基溴的职业接触限值。
Regul Toxicol Pharmacol. 2004 Oct;40(2):136-50. doi: 10.1016/j.yrtph.2004.06.006.
9
Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.双酚A口服参考剂量(RfD)及饮水等效浓度的推导
J Toxicol Environ Health B Crit Rev. 2008 Feb;11(2):69-146. doi: 10.1080/10937400701724303.
10
The current state of knowledge on the use of the benchmark dose concept in risk assessment.风险评估中基准剂量概念应用的当前知识状态。
J Appl Toxicol. 2008 May;28(4):405-21. doi: 10.1002/jat.1298.

引用本文的文献

1
Genome-Scale Metabolic Modeling Predicts Per- and Polyfluoroalkyl Substance-Mediated Early Perturbations in Liver Metabolism.全基因组尺度代谢模型预测全氟和多氟烷基物质介导的肝脏代谢早期扰动。
Toxics. 2025 Aug 17;13(8):684. doi: 10.3390/toxics13080684.
2
bmdrc: Python package for quantifying phenotypes from chemical exposures with benchmark dose modeling.BMDrc:用于通过基准剂量模型量化化学暴露表型的Python软件包。
PLoS Comput Biol. 2025 Jul 28;21(7):e1013337. doi: 10.1371/journal.pcbi.1013337. eCollection 2025 Jul.
3
Transgenerational toxicity of Aroclor 1232 by inhalational route in mouse model.
通过吸入途径在小鼠模型中研究多氯联苯混合物Aroclor 1232的跨代毒性。
Toxicol Rep. 2025 Jun 17;15:102072. doi: 10.1016/j.toxrep.2025.102072. eCollection 2025 Dec.
4
A phototaxis assay to measure sublethal effects of pesticides on bees.一种用于测量农药对蜜蜂亚致死效应的趋光性测定法。
Sci Rep. 2025 Jul 1;15(1):22136. doi: 10.1038/s41598-025-05400-7.
5
Synthesizing Genotoxicity Results in the MultiFlow Assay With Point-of-Departure Analysis and ToxPi Visualization Techniques.结合出发分析和ToxPi可视化技术,综合多流分析中的遗传毒性结果。
Environ Mol Mutagen. 2025 Mar;66(3):122-133. doi: 10.1002/em.70003. Epub 2025 Mar 13.
6
A Perspective from US Environmental Protection Agency (EPA) Scientists: How Your Epidemiologic Analyses Can Inform the Human Health Risk Assessment Process.美国环境保护局(EPA)科学家的观点:您的流行病学分析如何为人类健康风险评估过程提供信息。
Environ Health Perspect. 2025 Apr;133(3-4):45001. doi: 10.1289/EHP15203. Epub 2025 Apr 11.
7
A benchmark concentration-based strategy for evaluating the combined effects of genotoxic compounds in TK6 cells.一种基于基准浓度的策略,用于评估遗传毒性化合物在TK6细胞中的联合效应。
Arch Toxicol. 2025 Apr;99(4):1581-1589. doi: 10.1007/s00204-025-03971-y. Epub 2025 Feb 13.
8
Quantitative study on hepatic genotoxicity of neodymium and its molecular mechanisms based on Benchmark Dose method.基于基准剂量法的钕肝遗传毒性定量研究及其分子机制
Front Pharmacol. 2024 Dec 17;15:1484111. doi: 10.3389/fphar.2024.1484111. eCollection 2024.
9
Accelerating antiviral drug discovery: early hazard detection with a dual zebrafish and cell culture screen of a 403 compound library.加速抗病毒药物研发:通过斑马鱼和细胞培养双重筛选403种化合物文库进行早期风险检测
Arch Toxicol. 2025 Mar;99(3):1029-1041. doi: 10.1007/s00204-024-03948-3. Epub 2024 Dec 27.
10
Updated Risk Assessment of Cannabidiol in Foods Based on Benchmark Dose-Response Modeling.基于基准剂量-反应建模的食品中海藻糖的更新风险评估。
Molecules. 2024 Oct 7;29(19):4733. doi: 10.3390/molecules29194733.